QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 4, 2009-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Canaccord Adams 29^th Annual Growth Stock Conference in Boston on August 12, 2009 at 4:30 p.m. Eastern Time. Jan Keltjens, President and CEO, and Joseph Gersuk, Executive Vice President and CFO of AngioDynamics, will review the Company’s business strategy and historical financial results.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company’s website at: www.angiodynamics.com. The archived presentation will be available for 90 days.

About AngioDynamics

AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company’s diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Source: AngioDynamics

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk or Jenifer Kirtland, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
jkirtland@evcgroup.com
or
EVC Group, Inc.
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com